Recombinant Cartilage Oligomeric Matrix Protein (COMP) Homo sapiens (Human) Recombinant protein

MED; EDM1; EPD1; PSACH; THBS5; TSP-5; Pseudoachondroplasia,Epiphyseal Dysplasia 1,Multiple; Thrombospondin 5

  • Product No.RPB197Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted, extracellular space, extracellular matrix.
  • Predicted Molecular Mass16.5kDa
  • Accurate Molecular Massn/a(Analysis of differences refer to the manual)
  • Residues & TagsSer123~His240 (Accession # P49747) with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point7.2
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 1g In stock
  • FOB US$ 160.00 FREE TRIAL US$ 400.00 FREE TRIAL US$ 800.00 FREE TRIAL US$ 2,400.00 FREE TRIAL US$ 60,000.00 FREE TRIAL
  • Quantity
  • Add to Cart Distributors
  • Recombinant Cartilage Oligomeric Matrix Protein (COMP) Packages (Simulation)
  • Recombinant Cartilage Oligomeric Matrix Protein (COMP) Packages (Simulation)
  • RPB197Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE

USAGE

Reconstitute in PBS or others.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Chinese Medical Journal Genetic analysis and serum level of cartilage oligomeric matrix protein in patients with pseudoachondroplasia CMJ: 201082337960590

Recommend products